HALO logo
halo search icon
Pharvaris N.V.

US$30.54

Price Change Indicator
1.09 (3.70%)
Pharvaris N.V.
PHVS · NAS

Pharvaris N.V.

Start Trading PHVS for Free

US$30.54

Price Arrow1.09 (3.70%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Earnings MomentumHALO MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Pharvaris N.V. Overview

PHVS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About PHVS

icon

Website

Pharvaris N.V.

icon

Telephone

31.71.203.64.10

icon

Address

Emmy Noetherweg 2, Leiden, Zuid-Holland 2333 BK

Description

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

PHVS Price Chart

Key Stats

Market Cap

US$1.93B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 15.46 - 33.33

Trade Value (12mth)

US$1,428,310.00

1 week

-3.12%

1 month

-1.96%

YTD

11.22%

1 year

79.68%

All time high

42.86

Key Fundamentals

EPS 3 yr Growth

31.00%

EBITDA Margin

0.00%

Operating Cashflow

-€137m

Free Cash Flow Return

-51.80%

ROIC

-66.40%

Interest Coverage

-980.00

Quick Ratio

10.10

Other Data

Shares Outstanding (Fully Diluted)

65m

HALO Sector

Healthcare

Next Company Report Date

08-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

PHVS Announcements

Latest Announcements

DateAnnouncements
13 May 26
12 May 26
09 May 26
09 May 26
02 April 26

PHVS Fundamentals

Per Share Records

Historical data

Forecast data

EUR2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 €locklocklocklock-2.62-2.48-2.97locklocklock
EPS (Fully Diluted)
 €locklocklocklock-2.62-2.48-2.97locklocklock
Growth
 %locklocklocklock-15.85.4-19.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Pharvaris N.V. (PHVS:NAS)?
Halo FAQ
The current share price of Pharvaris N.V. (PHVS:NAS) is USD$30.54.
What is the 52-week high share price for Pharvaris N.V. (PHVS:NAS)?
Halo FAQ
The 52-week high share price for Pharvaris N.V. (PHVS:NAS) is USD$33.33.
What is the 52-week low share price for Pharvaris N.V. (PHVS:NAS)?
Halo FAQ
The 52-week low share price for Pharvaris N.V. (PHVS:NAS) is USD$15.46.
What is the dividend yield for Pharvaris N.V. (PHVS:NAS)?
Halo FAQ
Pharvaris N.V. (PHVS:NAS) does not pay a dividend.
What was Pharvaris N.V. (PHVS:NAS) last dividend payment?
Halo FAQ
Pharvaris N.V. (PHVS:NAS) does not pay a dividend.
What is the franking level for Pharvaris N.V. (PHVS:NAS)?
Halo FAQ
Pharvaris N.V. (PHVS:NAS) has a franking level of 0.00%.
In which sector is Pharvaris N.V. (PHVS:NAS) classified?
Halo FAQ
Pharvaris N.V. (PHVS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial